UNSPSC 51162204: Aminophylline/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE104. This VA Drug Class (RE104) classifies this compound as belonging to the group BRONCHODILATORS, XANTHINE-DERIVATIVE.

UNSPSC 51162204 Aminophylline/sodium chloride is a Commodity code for pharmaceutical products. State and local governments procure aminophylline and sodium chloride formulations under this code as part of broader multi-source generic pharmaceutical contracts serving health systems, correctional facilities, and other public medical facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary recent issuing body, establishing standing agreements for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in multiple states including Oregon. Vendors must supply through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and certify compliance with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), and FDA requirements. Products must be available in the marketplace by May 15, 2026, with awarded agreements effective July 1, 2026. Vendors must maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place and carry comprehensive insurance including $5,000,000 commercial general liability, $2,000,000 network security and privacy liability, and $2,000,000 professional liability.

MMCAP issued an RFP (S1070000015802) with a March 26, 2026 proposal deadline and a February 18, 2026 cutoff for questions. Pricing is weighted as the dominant evaluation criterion (75 percent), with secondary weight on fixed pricing for the contract term (10 percent), price competitiveness structures (flat price, net price formats, or WAC-minus), EDI capability (5 percent), compliance with administrative fee data format requirements (5 percent), and agreement to a 3 percent administrative fee (5 percent). The contract term runs two years for new responders with optional extensions at MMCAP's sole discretion, while incumbent responders' amendments align with existing agreement expiration dates through June 30, 2028. The RFP does not identify specific set-aside designations. Vendors should expect performance penalties ranging from $200 to $1,500 per violation for issues such as late reporting, missed onboarding timelines, or improper class-of-trade denials.